drug
pentostatin
Marketedupdated 3mo agoby Hikma Pharmaceuticals USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(12)
approval · 12
Oct 11, 1991
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Sep 29, 1993
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Jul 19, 1994
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Dec 24, 1997
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Oct 8, 1998
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Aug 2, 2001
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
May 23, 2002
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Sep 22, 2009
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Jun 20, 2013
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Dec 29, 2015
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Oct 28, 2019
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Nov 3, 2025
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Trials studying pentostatin
- phase3A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
- phase1Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
- phase2Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD
- phase2Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that